Raffaella Giuffrida

Viagrande, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Correction: Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.

Correction: Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.

Journal: Clinical and experimental medicine
Published: July 29, 2025

Single-Vesicle Molecular Profiling by dSTORM Imaging in a Liquid Biopsy Assay Predicts Early Relapse in Colorectal Cancer.

Single-Vesicle Molecular Profiling by dSTORM Imaging in a Liquid Biopsy Assay Predicts Early Relapse in Colorectal Cancer.

Journal: Biomolecules
Published: July 21, 2025

Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.

Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.

Journal: Clinical and experimental medicine
Published: May 29, 2025

Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation.

Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation.

Journal: Journal of translational medicine
Published: June 26, 2024

A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia.

A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia.

Journal: Cells
Published: April 23, 2024

Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796.

Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796.

Journal: Cancers
Published: December 07, 2023

Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance.

Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance.

Journal: Journal of translational medicine
Published: October 04, 2023

Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.

Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.

Journal: Frontiers in pharmacology
Published: July 13, 2023

Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).

Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).

Journal: Cancers
Published: April 17, 2023

Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value.

Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value.

Journal: Cells
Published: January 25, 2023

The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors.

The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors.

Journal: International journal of molecular sciences
Published: November 25, 2022
Showing 1-12 of 26

Last Updated: 09/26/2026